Vero Biotech
Jason Molinari currently serves as Senior Vice President Of New Product Development at Vero Biotech since October 2018. Previously, Molinari held the position of Operations Project Manager at MiMedx from April 2017 to October 2018 and served as Director of Research and Development at Facet Technologies LLC from January 2008 to March 2017, where leadership of an R&D team resulted in the successful launch of innovative diabetic devices. Earlier experience includes the role of Project Portfolio Manager at CIBA Vision/Novartis, focusing on project coordination across multiple manufacturing platforms. Jason Molinari holds a Bachelor of Science in Mechanical Engineering from the Georgia Institute of Technology and an MBA in Finance from Georgia State University.
Vero Biotech
Vero biotech is an emerging biotechnology company focused on the design, development, and commercialization of next-generation inhaled nitric oxide (NO) delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions.